Airway obstruction following bronchoscopic photodynamic therapy in early centrally located lung cancer requiring extracorporeal membrane oxygenation  by Chang, Yin-Chun et al.
Journal of the Formosan Medical Association (2013) 112, 54e56Available online at www.sciencedirect.com
journal homepage: www.j fma-onl ine.comCASE REPORT
Airway obstruction following bronchoscopic
photodynamic therapy in early centrally located
lung cancer requiring extracorporeal membrane
oxygenationYin-Chun Chang, Jang-Ming Lee*, Wen-Je Ko, Yung-Chie LeeDivision of Thoracic Surgery, Department of Surgery, National Taiwan University Hospital and National Taiwan University
College of Medicine, Taipei, Taiwan
Received 3 June 2009; received in revised form 25 August 2009; accepted 12 February 2010KEYWORDS
early lung cancer;
ECMO;
photodynamic
therapy* Corresponding author. Department
University Hospital, No. 7, Chung-Shan
E-mail address: ntuhlee@yahoo.co
0929-6646/$ - see front matter Copyr
http://dx.doi.org/10.1016/j.jfma.201Photodynamic therapy (PDT) is a treatment modality of early central located nonesmall-cell
lung cancer, and in patients who are unsuitable for surgical intervention. Most complications
of PDT reported in the literature are minor and can be easily handled. We report a case pre-
senting with nearly fatal complication: airway obstruction following bronchoscopic photody-
namic therapy for early endobronchial lung cancer, requiring extracorporeal membrane
oxygenation. An 81-year-old man was admitted to thoracic surgery division due to an early cen-
trally located lung cancer. Due to multiple comorbidity and high surgical risk we performed
bronchoscopic PDT instead of aggressive lung resection for the patient. After the procedure,
he developed severe airway obstruction by tumor debris and required temporary cardiopulmo-
nary support with extracorporeal membrane oxygenation. The patient recovered smoothly
after the episode and was free from tumor recurrence for >2 years without any neurological
sequelae.
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Photodynamic therapy (PDT) is a treatment modality of
early central located nonesmall-cell lung cancer, and in
patients who are unsuitable for surgical intervention. Most
complications of PDT reported in the literature are minor& Formosan Medical Association. All rights reserved.
Acute airway obstruction after photodynamic therapy for early lung cancer 55and can be easily handled. We report a case presenting with
nearly fatal complication.
Case report
An 81-year-old man was referred to the thoracic surgery
division with blood tinged sputum. The patient had the
multiple underlying diseases of diabetes mellitus, hyper-
tension, paroxysmal atrial fibrillation, chronic obstructive
pulmonary disease, right vertebral artery occlusion, and
coronary artery disease with one-vessel-occlusion. Investi-
gation with chest computer tomography revealed an
endobronchial lesion over left distal main bronchus
extended to left lower lobe bronchus and subsegmental
bronchiectasis at the superior segment of RLL (Fig. 1). The
lesion was 3 cm distal to the carina and causing 70% stenosis
of left main bronchus. Bronchoscopy examination showed
a left main bronchus tumor lesion with hemorrhage;
washing cytology showed squamous cell carcinoma. Lung
function showed moderate mixed ventilatory defect;
forced vital capacity (FVC) 2 L(59.8% predicted), forced
exhaled volume in the first second (FEV1) 1.3 L(53.5% pre-
dicted), FEV1/FVC 65%. Endobronchial ultrasound demon-
strated an endobronchial tumor with 1 cm in depth. Cancer
staging work-up showed no distant metastasis with clinical
stage IA disease. Due to high surgical risk bronchoscopic
photodynamic therapy (PDT) was performed instead of
aggressive lung resection for the patient.
PDT (200 J/cm2) via flexible a bronchoscope under general
anesthesia was performed. After the procedure, the patient
was transferred to the intensive care unit with an endotra-
cheal tube. Weaning from the ventilator was started 2 days
after the procedure, because post-PDT related airway
complications usually occur 1 to 3 days after procedure.
However, sudden onset of desaturation was noted on theFigure 1 Chest computed tomography revealed an endo-
bronchial lesion over the left distal main bronchus, extending
to the left lower lobe bronchus.third day after PDT, with O2 saturation reduced to below 70%
even under ventilator support with pure oxygen. Bronchos-
copy revealed total obstruction of left main bronchus by
swelling tumor debris (Fig. 2A). Venoarterial extracorporeal
membrane oxygenation (ECMO) was set up due to persistent
desaturation and unstable hemodynamic parameters. Rigid
bronchoscopic removal of endobronchial tumor was done
subsequently. After the tumor was removed, the airway
regained its patency (Fig. 2B,C). His pulmonary and general
condition improved soon after ECMO support and rigid bron-
choscopic debridement of tumor debris. ECMO was weaned 4
days after tumor removal because of the patient’s poor
cardiopulmonary function and high risk of progressive airway
swelling and obstruction by the residual tumor. The patient
was discharged 26 days after PDT with no obvious neurolog-
ical sequelae. Bronchoscopy in recent follow-up 25 months
after PDT revealed scar tissue in left main bronchus, and free
of tumor local recurrence for >2 years (Fig. 2D).Discussion
PDT is a novel treatment for variety of cancer that involves
a two-stage process: intravenous administration of
a photosensitizer that is selectively retained in higher
concentrations in the tumor than in surrounding normal
tissue, followed by photo-activation of the photosensitizer
by a specific wave length light. The photo-activation
induced cytotoxic effect of PDT was achieved by genera-
tion of free radicals in the cells. The first case of PDT
application in human lung cancer was performed in Tokyo
Medical University, Japan in 1980. The patient had an early
squamous cell carcinoma of the right upper bronchus, but
refused surgical intervention. The patient had disease free
survival for >5 years and died of nonpulmonary disease.
The largest series of lung cancer patients with early disease
who were treated by PDT has been reported by the Tokyo
Medical University group with 5-year survival rate of 68.4%.
When death due to other diseases was excluded, the rate
increased to 94.8%.1,2
The survival benefit of PDT in early lung cancer patients
who were ineligible for surgical resection has been well
documented.3 In the current literature, there is no
prospective or randomized control trial to compare of PDT
with surgery or other treatment modality in inoperable
early lung cancer patients. However, from the available
clinical reports, we believe that PDT could be considered as
an effective treatment modality in inoperable early lung
cancer cases.
The major adverse effect of PDT is skin photosensitivity,
which can last as long as 4 to 6 weeks. Sunburn is the most
common clinical presentation (skin erythema, blister
formation). Post-PDT mild hemoptysis, cough, and chest
discomfort are also common. Other complications included
pneumothorax, TE fistula, and airway obstruction by tumor
debris.4 Post-PDT related airway obstruction is a major
complication especially in patients with poor pulmonary
function. The mechanism of airway obstruction after PDT is
usually caused by postirradiation airway swelling and
necrotic tumor debris. Toilet bronchoscopy should be
usually performed 1 to 3 days after initial PDT to prevent
airway obstruction by tumor debris, which usually requires
Figure 2 (A) Bronchoscopy showed that the left main bronchus was totally obstructed by tumor debris after photodynamic
therapy. (B) Patency of the left main bronchus was recovered after rigid bronchoscopic removal of tumor debris. (C) Specimen of
endobronchial tumor debris. (D) Bronchoscopy in the left main bronchus 25 months after photodynamic therapy.
56 Y.-C. Chang et al.removal by rigid bronchoscopy. This is first report in the
literature of PDT-induced airway obstruction requiring
ECMO support before definite treatment to release the
airway obstruction. Yamagishi et al reported two cases of
trachea obstruction by cancer and tuberculosis respectively
who were successfully managed by venovenous ECMO and
both of whom survived after the episodes.5 In our case,
ECMO was essential to manage a life-threatening airway
obstruction after PDT for an early centrally-located lung
cancer, as it allowed subsequent tumor debris debridement
to relieve the airway obstruction.
In summary, PDT is an effective modality in inoperable
early central located nonesmall-cell lung cancer patients.
Early postoperative toilet bronchoscopies should be
emphasized to minimize the risk of bronchial obstruction,
which could result in fatal complications. ECMO could be
useful to temporarily cardio-pulmonary support in such
cases before definitive treatment for the airway obstruction.References
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